Type Public | Parent organization Prestige Brands | |
 | ||
Traded as NYSE: PBH
S&P 400 Component Industry Over-The-Counter Healthcare products, and Household Cleaning products Founded 1996; 21 years ago (1996) Revenue US$ 602.0 million (fiscal 2014) Operating income Stock price PBH (NYSE) US$ 55.94 -0.12 (-0.21%)24 Mar, 4:02 PM GMT-4 - Disclaimer Headquarters Greenburgh, New York, United States CEO Matthew M. Mannelly (3 Sep 2009–) Subsidiaries The Spic and Span Company Profiles | ||
Top 100 prestige brands in china
Prestige Brands Holdings, Inc. is a company that markets and distributes Over-The-Counter Healthcare and Household Cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and The Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York.
Contents
Among the brands owned by Prestige Brands are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC & Goody's Headache Powders, Pediacare & Little Remedies children's OTC products, Beano (dietary supplement), Comet and Spic and Span household cleaning products.
The company's CEO and president is Ron Lombardi, who replaced Mathew Mannelly on 1 June 2015.
History
Prestige Brands Holdings, Inc. was established in 1999 to acquire, revitalize, and line extend leading, often neglected but healthy brands that were considered non-core at major consumer products companies. In 2004, MidOcean Partners sold Prestige Brands to GTCH Golder Rauner.
Acquisitions:
The Company acquired Blacksmith Brands' portfolio of 5 brands in 2010.
In December 2011, the Company agreed to purchase 17 brands from GlaxoSmithKline which included BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex and Tagamet for $660 Million.
In 2013, Prestige Brands Holdings, Inc. acquired Care Pharmaceuticals of Bondi Junction, New South Wales Australia, a privately held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults.
In 2014, the Company purchased Hydralyte™ in Australia and New Zealand from The Hydration Pharmaceuticals Trust of Victoria, Australia. Hydralyte is the leading oral rehydration product in Australia & New Zealand.
In April 2014, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter healthcare products, for $750 million in cash.
In November 2015, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire DenTek Oral Care, Inc. (“DenTek”), a privately-held marketer and distributor of oral care products for $225 million in cash.
In December 2016, Prestige Brands Holdings Inc., home to brands including Monistat, Dramamine and Luden’s, has agreed to buy C.B. Fleet Co. from private-equity firm Gryphon Investors for about $825 million.
Divestitures:
In 2009, Prestige sold its Denorex and Prell brands of shampoo.
In 2012, The Company divested its Phazyme gas treatment brand.
In June 2016, The Company divested its Fiber Choice, PediaCare and New-Skin brands.
In December 2016, The company divested its Dermoplast brand.
In December 2016, The company licensed its Massengill brand.